Diabetes and; Endocrinology
Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes. Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones.
Scientists, Doctors, Academician, Researchers, Students, Business Entrepreneurs, etc related to the broad areas of Diabetes, Endocrinology, Medical and Health care, Diabetes and Endocrinology organizations are most likely to attend conferences and utilize the scope of extending their skills, and their work on basic and significant applications.
Market Research on Diabetes and; Endocrinology
Extensive market research carried out by the analysts at Technavio has shown that the global Endocrinology market will grow steadily at a CAGR of more than 6% over the forecast period. An increase in the prevalence of hormone-related disorders such as diabetes, hypogonadism, hypothyroidism, and hyperthyroidism is one of the key factors driving the growth of this market over the forecast period. The prevalence of Diabetes is on the rise owing to obesity, unhealthy diet, and lack of physical activity among individuals. According to many research studies, nearly 415 million individuals were affected by diabetes in 2015 and this number is likely to reach 642 million by 2040. Moreover, with the growing prevalence of hypogonadism in men due to diabetes and heart or renal diseases, it is estimated that the intake of medications will increase. This increase in the intake of medications will propel the prospects for growth in this market during the next four years.